| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2d6a64b7e756b8d86ed3fad75cbc4eb9 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2267-0381
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2267-03
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2267-025
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2217-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-70539
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-8509 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-85
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-74 |
| filingDate |
1993-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_54c24365642b9e799d6ad53596cb82cc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f27a6561271be27631fa47e85afd3d15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c8395c338ed9ce2d36091e491815d871 |
| publicationDate |
1994-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-9416065-A1 |
| titleOfInvention |
Producing cells for transplantation to reduce host rejection and resulting cells |
| abstract |
A method for treating cells with E19 protein in order to alter the presentation of MHC class I cell surface antigens on these cells and thereby allow introduction of these cells into a recipient organism while reducing transplant rejection by the recipient organism's immune system is described. The cells may be contacted with E19 protein by the presence in the cells of a vector which carries and expresses the E19 coding sequence or by the presence in the cells of a transgene with expresses the E19 coding sequence. The method may be used for treating a genetic disorder, a wound, a burn, or a disease, or for effecting gene therapy in a recipient organism. Transgenic and chimeric organisms, and cells are also provided. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6156306-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9506744-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9506744-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9506717-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9506717-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9631241-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6451571-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9526740-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9625177-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2730411-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7485293-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9614874-A1 |
| priorityDate |
1992-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |